title: Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimens.
authors.forename: S
authors.initials: S
authors.lastname: Chiara
authors.forename: E
authors.initials: E
authors.lastname: Campora
authors.forename: L
authors.initials: L
authors.lastname: Merlini
authors.forename: C
authors.initials: C
authors.lastname: Simoni
authors.forename: L
authors.initials: L
authors.lastname: Iskra
authors.forename: F
authors.initials: F
authors.lastname: Odicino
authors.forename: N
authors.initials: N
authors.lastname: Ragni
authors.forename: P F
authors.initials: PF
authors.lastname: Conte
authors.forename: R
authors.initials: R
authors.lastname: Rosso
mesh_terms: D002945:Cisplatin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012189:Retrospective Studies; D016879:Salvage Therapy
chemical_list: D002945:Cisplatin